From Casetext: Smarter Legal Research

Dickerson v. Intercept Pharm.

United States District Court, S.D. New York
Jan 9, 2024
23 Civ. 9121 (AT) (S.D.N.Y. Jan. 9, 2024)

Opinion

23 Civ. 9121 (AT)

01-09-2024

JOHN DICKERSON, Plaintiff, v. INTERCEPT PHARMACEUTICALS, INC., JEROME DURSO, PAOLO FUNDARO, MARK PRUZANSKI, SRINIVAS AKKARAJU, LUCA BENATTI, DANIEL BRADBURY, KEITH GOTTESDIENER, NANCY MILLER-RICH, DAGMAR ROSA-BJORKESON, GINO SANTINI, and GLENN SBLENDORIO, Defendants.


ORDER

ANALISA TORRES, DISTRICT JUDGE:

On October 20, 2023, the Court ordered the parties to submit a joint letter and proposed case management plan by December 15, 2023. ECF No. 8. On December 18, 2023, having received no submissions, the Court extended the deadline to January 8, 2024. ECF No. 13. Those submissions are now overdue.

Accordingly, by January 24, 2024, the parties shall submit their joint letter and proposed case management plan, or Plaintiff shall file a letter stating his intentions regarding the prosecution of this action. Plaintiff is advised that failure to comply with the Court's orders will result in dismissal for failure to prosecute.

SO ORDERED.


Summaries of

Dickerson v. Intercept Pharm.

United States District Court, S.D. New York
Jan 9, 2024
23 Civ. 9121 (AT) (S.D.N.Y. Jan. 9, 2024)
Case details for

Dickerson v. Intercept Pharm.

Case Details

Full title:JOHN DICKERSON, Plaintiff, v. INTERCEPT PHARMACEUTICALS, INC., JEROME…

Court:United States District Court, S.D. New York

Date published: Jan 9, 2024

Citations

23 Civ. 9121 (AT) (S.D.N.Y. Jan. 9, 2024)